Lacticin 481
| Internal ID | a1362874-29c5-4191-8399-7ee08dd12268 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[(8Z)-29,35-bis(2-amino-2-oxoethyl)-20-(3-amino-3-oxopropyl)-11,17-dibenzyl-45-butan-2-yl-53-(2-carboxyethyl)-42-[[2-[[2-[[2-[[2-[[2-[[2-[[2-(2,6-diaminohexanoylamino)acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-8-ethylidene-50-(1H-imidazol-4-ylmethyl)-23-(1H-indol-3-ylmethyl)-41-methyl-32-(2-methylsulfanylethyl)-7,10,13,16,19,22,25,28,31,34,37,43,46,48,51,54,61-heptadecaoxo-14-propan-2-yl-3,40,57-trithia-6,9,12,15,18,21,24,27,30,33,36,44,47,49,52,55,60-heptadecazatricyclo[36.9.8.65,26]henhexacontane-59-carbonyl]amino]-3-hydroxypropanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C127H182N36O35S4/c1-12-63(8)101(161-123(193)99(61(4)5)159-97(171)51-138-105(175)85(52-164)141-96(170)50-136-95(169)49-137-104(174)72(129)30-23-24-37-128)124(194)152-82(43-70-48-134-60-140-70)116(186)163-103-65(10)202-58-91-121(191)150-83(44-93(131)167)113(183)145-77(36-38-199-11)109(179)149-84(45-94(132)168)114(184)155-87-54-200-55-88(119(189)153-86(53-165)127(197)198)156-120(190)89(56-201-57-90(158-125(195)102(64(9)13-2)162-126(103)196)118(188)148-81(42-69-47-133-59-139-69)112(182)144-76(108(178)157-91)33-35-98(172)173)154-106(176)73(14-3)142-110(180)78(39-66-25-17-15-18-26-66)151-122(192)100(62(6)7)160-115(185)79(40-67-27-19-16-20-28-67)146-107(177)75(32-34-92(130)166)143-111(181)80(147-117(87)187)41-68-46-135-74-31-22-21-29-71(68)74/h14-22,25-29,31,46-48,59-65,72,75-91,99-103,135,164-165H,12-13,23-24,30,32-45,49-58,128-129H2,1-11H3,(H2,130,166)(H2,131,167)(H2,132,168)(H,133,139)(H,134,140)(H,136,169)(H,137,174)(H,138,175)(H,141,170)(H,142,180)(H,143,181)(H,144,182)(H,145,183)(H,146,177)(H,147,187)(H,148,188)(H,149,179)(H,150,191)(H,151,192)(H,152,194)(H,153,189)(H,154,176)(H,155,184)(H,156,190)(H,157,178)(H,158,195)(H,159,171)(H,160,185)(H,161,193)(H,162,196)(H,163,186)(H,172,173)(H,197,198)/b73-14- |
| InChI Key | VIEVUPYQRUJFFA-XFKIZFQISA-N |
| Popularity | 123 references in papers |
| Molecular Formula | C127H182N36O35S4 |
| Molecular Weight | 2901.30 g/mol |
| Exact Mass | 2900.2484712 g/mol |
| Topological Polar Surface Area (TPSA) | 1230.00 Ų |
| XlogP | -10.50 |
| Atomic LogP (AlogP) | -11.65 |
| H-Bond Acceptor | 41 |
| H-Bond Donor | 38 |
| Rotatable Bonds | 54 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9301 | 93.01% |
| Caco-2 | - | 0.8573 | 85.73% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Mitochondria | 0.4323 | 43.23% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7996 | 79.96% |
| OATP1B3 inhibitior | + | 0.9322 | 93.22% |
| MATE1 inhibitior | - | 0.8074 | 80.74% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9665 | 96.65% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8690 | 86.90% |
| CYP3A4 substrate | + | 0.7648 | 76.48% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8531 | 85.31% |
| CYP3A4 inhibition | - | 0.8610 | 86.10% |
| CYP2C9 inhibition | - | 0.7491 | 74.91% |
| CYP2C19 inhibition | - | 0.7516 | 75.16% |
| CYP2D6 inhibition | - | 0.9024 | 90.24% |
| CYP1A2 inhibition | - | 0.8238 | 82.38% |
| CYP2C8 inhibition | + | 0.8661 | 86.61% |
| CYP inhibitory promiscuity | - | 0.8754 | 87.54% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.5761 | 57.61% |
| Eye corrosion | - | 0.9839 | 98.39% |
| Eye irritation | - | 0.8951 | 89.51% |
| Skin irritation | - | 0.7592 | 75.92% |
| Skin corrosion | - | 0.9195 | 91.95% |
| Ames mutagenesis | - | 0.7000 | 70.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7266 | 72.66% |
| Micronuclear | + | 0.7400 | 74.00% |
| Hepatotoxicity | - | 0.5500 | 55.00% |
| skin sensitisation | - | 0.8408 | 84.08% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.8076 | 80.76% |
| Acute Oral Toxicity (c) | III | 0.5891 | 58.91% |
| Estrogen receptor binding | - | 0.6466 | 64.66% |
| Androgen receptor binding | + | 0.7631 | 76.31% |
| Thyroid receptor binding | + | 0.8424 | 84.24% |
| Glucocorticoid receptor binding | + | 0.8688 | 86.88% |
| Aromatase binding | + | 0.8383 | 83.83% |
| PPAR gamma | + | 0.7956 | 79.56% |
| Honey bee toxicity | - | 0.5979 | 59.79% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5100 | 51.00% |
| Fish aquatic toxicity | + | 0.9675 | 96.75% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.98% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.92% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.79% | 91.11% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 99.62% | 94.75% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.52% | 96.09% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 99.47% | 88.42% |
| CHEMBL236 | P41143 | Delta opioid receptor | 99.37% | 99.35% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.06% | 97.64% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.84% | 96.61% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 98.68% | 95.56% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.36% | 97.23% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.03% | 90.08% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 97.67% | 93.10% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 97.41% | 88.56% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 97.29% | 94.62% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 97.21% | 88.10% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 96.86% | 95.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.80% | 96.47% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.60% | 98.33% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.21% | 99.17% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 96.19% | 90.20% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.12% | 90.17% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.07% | 98.05% |
| CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 95.01% | 94.08% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 95.01% | 95.71% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.57% | 94.66% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.30% | 97.09% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 94.24% | 96.90% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.88% | 94.45% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 93.79% | 100.00% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 92.79% | 95.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 92.46% | 99.23% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 92.09% | 96.11% |
| CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 | 91.99% | 94.23% |
| CHEMBL233 | P35372 | Mu opioid receptor | 91.81% | 97.93% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 91.25% | 98.59% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.27% | 82.69% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 89.79% | 82.86% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.16% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 88.90% | 93.56% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 88.34% | 95.93% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.25% | 93.00% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 88.21% | 96.31% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 87.82% | 95.00% |
| CHEMBL1829 | O15379 | Histone deacetylase 3 | 87.76% | 95.00% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 87.08% | 97.21% |
| CHEMBL5805 | Q9NR97 | Toll-like receptor 8 | 87.08% | 96.25% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 87.03% | 82.38% |
| CHEMBL4801 | P29466 | Caspase-1 | 86.77% | 96.85% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 86.61% | 85.14% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.24% | 98.75% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 85.95% | 95.50% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 85.35% | 92.32% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.82% | 96.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 84.71% | 89.00% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 84.63% | 91.71% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 84.46% | 95.83% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 84.15% | 97.14% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 83.75% | 100.00% |
| CHEMBL1949 | P62937 | Cyclophilin A | 83.48% | 98.57% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 83.30% | 99.15% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 83.18% | 89.33% |
| CHEMBL211 | P08172 | Muscarinic acetylcholine receptor M2 | 82.99% | 94.97% |
| CHEMBL4071 | P08311 | Cathepsin G | 82.68% | 94.64% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 82.40% | 90.71% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 82.24% | 90.24% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 82.21% | 94.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 81.36% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.05% | 95.89% |
| CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor | 81.04% | 90.71% |
| CHEMBL3891 | P07384 | Calpain 1 | 80.69% | 93.04% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 80.17% | 96.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 80.05% | 95.38% |
| CHEMBL202 | P00374 | Dihydrofolate reductase | 80.04% | 89.92% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587345 |
| LOTUS | LTS0172084 |
| wikiData | Q105286805 |